miR-196b靶向ERG促进肺腺癌的增殖和迁移

刘邦卿; 李剑锋; 刘晓辉; 张劲男; 梁金屏

doi:10.12259/j.issn.2095-610X.S20231023

miR-196b靶向ERG促进肺腺癌的增殖和迁移

doi: 10.12259/j.issn.2095-610X.S20231023

1.
唐山市人民医院胸外二科
2.
头颈外科，河北唐山　063000

基金项目: 河北省医学科学研究课题基金资助项目（20231805）

详细信息

作者简介:
刘邦卿（1988～），男，山东巨野人，医学硕士，主治医师，主要从事肺癌基础与临床研究工作

中图分类号: R734.2
计量
- 文章访问数: 1700
- HTML全文浏览量: 866
- PDF下载量: 17
- 被引次数: 0
出版历程
- 收稿日期: 2023-06-26
- 网络出版日期: 2023-09-12
- 刊出日期: 2023-10-25

MiR-196b Promotes Proliferation and Migration of Lung Adenocarcinoma by Targeting ERG

1.
The 2nd Dept. of Thoracic Surgery
2.
Dept. of Head and Neck Surgery，Tangshan People’s Hospital，Tangshan Hebei 063000，China

摘要

摘要: 目的探究miR-196b影响肺腺癌（lung adenocarcinoma，LUAD）进展的机制。方法通过TCGA数据库分析miR-196b在LUAD组织中的表达水平，利用TargetScan预测其下游靶基因并用双荧光素酶实验进行验证，qRT-PCR检测miR-196b和ETS相关基因（ETS-related gene，ERG）在LUAD细胞系中的表达情况，MTT、划痕愈合和Transwell实验分别检测不同处理后LUAD细胞的增殖、迁移和侵袭能力的变化情况。结果 miR-196b在LUAD中高表达（P = 3.50e-17）并靶向负调控ERG，过表达miR-196b能够促进LUAD细胞的增殖、迁移和侵袭（P < 0.05），回复实验证实miR-196b/ERG调控轴能够影响LUAD细胞增殖、迁移和侵袭（P < 0.05）。结论 miR-196b靶向ERG促进LUAD进展的分子机制，对开发LUAD新的临床治疗方法具有潜在意义。
- miR-196b /
- ERG /
- 肺腺癌 /
- 增殖 /
- 迁移
Abstract: Objective To explore the mechanisms of miR-196b affecting the progression of lung adenocarcinoma （LUAD）. Methods The expression level of miR-196b in LUAD tissues was analyzed through TCGA database. TargetScan was used to predict its downstream target genes, and dual-luciferase assay was performed to validate the predictions. qRT-PCR was used to detect the expression of miR-196b and ETS-related gene （ERG） in LUAD cell lines. MTT, scratch healing, and Transwell assays were used to respectively assess the changes in proliferation, migration, and invasion abilities of LUAD cells after different treatments. Results miR-196b was highly expressed in LUAD （P = 3.50e-17） and negatively regulated ERG. Overexpression of miR-196b promoted proliferation, migration, and invasion of LUAD cells （P < 0.05）. Rescue experiments confirmed that miR-196b/ERG regulatory axis can affect the proliferation, migration, and invasion of LUAD cells （P < 0.05）. Conclusion The molecular mechanism of miR-196b targeting ERG in promoting the progression of LUAD has potential significance for the development of new clinical treatment methods for LUAD.
- miR-196b /
- ERG /
- Lung adenocarcinoma /
- Proliferation /
- Migration

HTML全文

图 1 miR-196b和ERG在肺腺癌中的表达情况

A：通过TCGA数据库预测miR-196b在正常组织和肺腺癌组织中的表达，绿框图表示正常样本（n = 46），红框图表示肿瘤样本（n = 521）；B：肺腺癌患者miR-196b表达水平与总生存率的K-M分析，红色表示高表达组，蓝色表示低表达组；C：通过TCGA数据库预测正常组织和肺腺癌组织中ERG的表达，绿框图表示正常样本（n = 59），红框图表示肿瘤样本（n = 535）。

Figure 1. Expression of miR-196b and ERG in lung adenocarcinoma

下载: 全尺寸图片幻灯片

图 2 miR-196b在肺腺癌细胞中的表达情况

与BEAS-2B组比较，^*P < 0.05。

Figure 2. Expression of miR-196b in lung adenocarcinoma cells

下载: 全尺寸图片幻灯片

图 3 miR-196b可影响肺腺癌细胞的增殖、迁移和侵袭

A：qRT-PCR检测过表达或敲低miR-196b后细胞的转染效率；B：MTT法检测过表达或敲低miR-196b后细胞的增殖能力；C：划痕愈合实验检测过表达或敲低miR-196b后细胞的迁移能力；D：Transwell实验检测过表达或敲低miR-196b后细胞的迁移和侵袭能力（100×）。与NC组比较，^*P < 0.05。

Figure 3. miR-196b can affect the proliferation，migration and invasion of lung adenocarcinoma cells

下载: 全尺寸图片幻灯片

图 4 miR-196b的靶点检测及不同处理组细胞中ERG 的表达情况

A：通过TargetScan数据库预测miR-196b和ERG的靶向结合位点；B：双荧光素酶法检测miR-196b与ERG的靶向结合关系；C：采用qRT-PCR和Western blot检测各细胞系中ERG mRNA和蛋白的表达；D：采用qRT-PCR和Western blot检测不同处理组ERG mRNA和蛋白的表达。与NC组或BEAS-2B组做比较，^*P < 0.05。

Figure 4. Target detection of miR-196b and expression of ERG in cells of different treatment groups

下载: 全尺寸图片幻灯片

图 5 miR-196b能靶向下调ERG促进肺腺癌细胞的增殖、迁移和侵袭能力

A：采用qRT-PCR和Western blot检测不同处理组大鼠ERG mRNA和蛋白的表达；B：MTT实验检测不同处理组的细胞增殖能力；C：划痕愈合实验检测不同处理组细胞迁移能力；D：Transwell实验检测不同处理组细胞的迁移和侵袭能力（100×）。NC-mimic、NC-inhibitor、oe-NC和si-NC分别表示miR-196b过表达、miR-196b沉默、ERG过表达和ERG沉默对照组，miR-mimic和miR-inhibitor分别表示miR-196b过表达和沉默组，oe-ERG和si-ERG分别表示ERG过表达组和沉默组；miR-mimic/inhibitor + oe/si-NC与NC组比较，miR-mimic/inhibitor + oe/si-NC组与miR-mimic/inhibitor + oe/si-ERG组比较，^*P < 0.05，。

Figure 5. miR-196b can target down regulate ERG to promote the proliferation，migration and invasion of lung adenocarcinoma cells

下载: 全尺寸图片幻灯片

表 1 研究使用的细胞系及培养基

Table 1. Cell lines and media used in the study

细胞系	编号	培养基
BEAS-2B	BNCC338205	DMEM-H
PC-9	BNCC340767	DMEM-H
HCC-78	BNCC338064	RPMI-1640
H1395	BNCC255519
Calu-3	BNCC338514

下载: 导出CSV

表 2 引物序列表

Table 2. Primer Sequence Table

基因	引物序列（5′→ 3′）
miR-196b	Forward primer: GTACCACTTTATCCCGTTCACCA Reverse primer:ATCTCGAGGCAGGGAGAGAGGAATAA
U6	Forward primer: GCCCATCTTGACCCGAAT
U6	Reverse primer: AACGCTTCACGAATTTGCGT
ERG	Forward primer:GAGTGGGCGGTGAAAGAATA
ERG	Reverse primer: GGAGATGTGAGAGAAGAGTG
GAPDH	Forward primer:CTCCTCCTGTTCGACAGTCAGC
GAPDH	Reverse primer:CCCAATACGACCAAATCCGTT

下载: 导出CSV

参考文献(36)

[1]	Luo C,Lei M,Zhang Y,et al. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma[J]. J Cell Mol Med,2020,24(2):1233-1244. doi: 10.1111/jcmm.14719
[2]	Seguin L,Durandy M,Feral C C. Lung adenocarcinoma tumor origin: A Guide for personalized medicine[J]. Cancers (Basel),2022,14(7):1759. doi: 10.3390/cancers14071759
[3]	Siegel R L,Miller K D,Jemal A. Cancer statistics,2016[J]. CA Cancer J Clin,2016,66(1):7-30. doi: 10.3322/caac.21332
[4]	Guo T,Li J,Zhang L,et al. Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer[J]. J Cancer Res Clin Oncol,2019,145(1):31-48. doi: 10.1007/s00432-018-2767-5
[5]	Xin H,Wang C,Chi Y,et al. MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5[J]. Cancer Cell Int,2020,20:119. doi: 10.1186/s12935-020-01200-3
[6]	Shao L,Chen Z,Peng D,et al. Methylation of the HOXA10 promoter directs miR-196b-5p-dependent cell proliferation and invasion of gastric cancer cells[J]. Mol Cancer Res,2018,16(4):696-706. doi: 10.1158/1541-7786.MCR-17-0655
[7]	Chen L,Tang H,Liu G,et al. MicroRNA-196b promotes gastric cancer progression by targeting ECRG4[J]. Anticancer Drugs,2021,32(2):127-137. doi: 10.1097/CAD.0000000000000998
[8]	Wu X, Wu G, Zhang H, et al. MiR-196b promotes the invasion and migration of lung adenocarcinoma cells by targeting AQP4 [J]. Technol Cancer Res Treat, 2021, 20: 1533033820985868.
[9]	Xu Q,Xu Z. miR-196b-5p promotes proliferation,migration and invasion of lung adenocarcinoma cells via targeting RSPO2[J]. Cancer Manag Res,2020,12:13393-13402. doi: 10.2147/CMAR.S274171
[10]	Li H,Feng C,Shi S. miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6[J]. Oncol Lett,2018,16(1):247-252.
[11]	Tharakan B,Hunter F A,Muthusamy S,et al. ETS-related gene activation preserves adherens junctions and permeability in microvascular endothelial cells[J]. Shock,2022,57(2):309-315. doi: 10.1097/SHK.0000000000001899
[12]	Khosh Kish E,Choudhry M,Gamallat Y,et al. The expression of proto-oncogene ETS-related gene (ERG) plays a central role in the oncogenic mechanism involved in the development and progression of prostate cancer[J]. Int J Mol Sci,2022,23(9):4772. doi: 10.3390/ijms23094772
[13]	Lorenzoni M,De Felice D,Beccaceci G,et al. ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3beta dependent Nkx3.1 degradation[J]. Cancer Lett,2022,534:215612. doi: 10.1016/j.canlet.2022.215612
[14]	He Y,Tao W,Shang C,et al. Xeroderma pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARgamma pathway[J]. Int J Exp Pathol,2021,102(3):157-162. doi: 10.1111/iep.12396
[15]	Robinson M D,McCarthy D J,Smyth G K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data[J]. Bioinformatics,2010,26(1):139-140. doi: 10.1093/bioinformatics/btp616
[16]	Zhang B,Chen M,Jiang N,et al. A regulatory circuit of circ-MTO1/miR-17/QKI-5 inhibits the proliferation of lung adenocarcinoma[J]. Cancer Biol Ther,2019,20(8):1127-1135. doi: 10.1080/15384047.2019.1598762
[17]	Sheng K,Lu J,Zhao H. ELK1-induced upregulation of lncRNA HOXA10-AS promotes lung adenocarcinoma progression by increasing Wnt/beta-catenin signaling[J]. Biochem Biophys Res Commun,2018,501(3):612-618. doi: 10.1016/j.bbrc.2018.04.224
[18]	宋家美,刘洋,史涛,等. DATS调控VEGF信号轴改善URSA小鼠胎盘血管的形成[J]. 昆明医科大学学报.,2023,44(5):6-11.
[19]	徐冬杏,唐波,朱国,等. Twist1调控Bmi1对胆囊癌细胞侵袭迁移的影响及其机制研究[J]. 昆明医科大学学报,2023,44(3):28-33.
[20]	Wei K,Ma Z,Yang F,et al. M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942[J]. Cancer Lett,2022,526:205-216. doi: 10.1016/j.canlet.2021.10.045
[21]	Xiong Y,Feng Y,Zhao J,et al. TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-beta signaling pathway[J]. Cell Death Dis,2021,12(4):352. doi: 10.1038/s41419-021-03606-x
[22]	Lu J,Lin J,Zhou Y,et al. MiR-328-3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1[J]. Biochem Biophys Res Commun,2021,550:99-106. doi: 10.1016/j.bbrc.2021.02.029
[23]	Zhang J,Yang W,Xiao Y,et al. MiR-125b inhibits cell proliferation and induces apoptosis in human colon cancer SW480 cells via targeting STAT3[J]. Recent Pat Anticancer Drug Discov,2022,17(2):187-194. doi: 10.2174/1574892816666210708165037
[24]	Angeles AK,Heckmann D,Flosdorf N,et al. The ERG-regulated LINC00920 promotes prostate cancer cell survival via the 14-3-3epsilon-FOXO pathway[J]. Mol Cancer Res,2020,18(10):1545-1559. doi: 10.1158/1541-7786.MCR-20-0021
[25]	Smolarz B,Durczynski A,Romanowicz H,et al. miRNAs in cancer (review of literature)[J]. Int J Mol Sci,2022,23(5):2805. doi: 10.3390/ijms23052805
[26]	Singh A P,Luo H,Matur M,et al. A coordinated function of lncRNA HOTTIP and miRNA-196b underpinning leukemogenesis by targeting FAS signaling[J]. Oncogene,2022,41(5):718-731. doi: 10.1038/s41388-021-02127-3
[27]	Dioguardi M,Cantore S,Sovereto D,et al. Potential role of miR-196a and miR-196b as prognostic biomarkers of survival in head and neck squamous cell carcinoma: A systematic review,meta-analysis and trial sequential analysis[J]. Life (Basel),2022,12(8):1269. doi: 10.3390/life12081269
[28]	Adamo P,Ladomery M R. The oncogene ERG: A key factor in prostate cancer[J]. Oncogene,2016,35(4):403-414. doi: 10.1038/onc.2015.109
[29]	Kulda V,Topolcan O,Kucera R,et al. Prognostic significance of TMPRSS2-ERG fusion gene in prostate cancer[J]. Anticancer Res,2016,36(9):4787-4793. doi: 10.21873/anticanres.11037
[30]	Hagglof C,Hammarsten P,Stromvall K,et al. TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers[J]. PLoS One,2014,9(2):e86824. doi: 10.1371/journal.pone.0086824
[31]	Wei Y,Peng J,He S,et al. miR-223-5p targeting ERG inhibits prostate cancer cell proliferation and migration[J]. J Cancer,2020,11(15):4453-4463. doi: 10.7150/jca.44441
[32]	Moh-Moh-Aung A,Fujisawa M,Ito S,et al. Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression[J]. Sci Rep,2020,10(1):10418. doi: 10.1038/s41598-020-67425-4
[33]	Yue C,Ma H,Zhou Y. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma[J]. PeerJ,2019,7:e8128. doi: 10.7717/peerj.8128
[34]	Tang Q,Chen J,Di Z,et al. TM4SF1 promotes EMT and cancer stemness via the Wnt/beta-catenin/SOX2 pathway in colorectal cancer[J]. J Exp Clin Cancer Res,2020,39(1):232. doi: 10.1186/s13046-020-01690-z
[35]	Gao C,Yao H,Liu H,et al. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer[J]. BMC Cancer,2019,19(1):237. doi: 10.1186/s12885-019-5417-7
[36]	Peng X C,Zeng Z,Huang Y N,et al. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer[J]. Cancer Med,2018,7(6):2592-2600. doi: 10.1002/cam4.1494

相关文章(20)

[1]	胡滔, 吴怡, 耿文达, 章意坚, 贺瑄, 李珊珊, 习杨彦彬, 邓丽玲. 自主运动训练通过调节Caspase-3的活性抑制人BRCA1突变乳腺癌的增殖与生长, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230419
[2]	张梁, 王保全, 雷喜锋, 王旭, 柯阳, 张玮. miR-29c-3p/IGF1分子轴对肝星状细胞活化，增殖和凋亡的作用机制, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230926
[3]	马诗淇, 丁毅, 李敏, 王梦慈, 张思宇, 冯树梅. LINC00341通过MAPK通路抑制肺腺癌细胞增殖, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230403
[4]	赵华君, 潘国庆, 唐莹, 王智园, 赵晓玮, 陀晓宇. ROR1在肺腺癌组织中的表达与气腔播散相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221128
[5]	吴茂芳, 周永春, 蔡静静, 莫欣, 李瑛玮, 毛佳惠. 云南地区多结节肺腺癌EGFR突变及其临床意义, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220215
[6]	张黎, 王清岑, 周罗慧, 杨娟, 王红. 木犀草素通过调控内质网应激抑制平滑肌细胞的迁移, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220518
[7]	王保全, 张伟, 田园, 雷喜锋, 王旭. miR-142-5p通过CCND1调控胆囊癌细胞的增殖和转移, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220223
[8]	张玮, 王保全, 雷喜锋, 王旭, 张梁. miR-125b-5p调控HK2抑制胆囊癌细胞增殖和糖酵解, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221206
[9]	朱中山, 杨洲, 江承川, 李小兵, 任斗, 黄橙, 张维薇, 李湘军, 赵顺利. 肺腺癌患者PLA2G1B表达情况与预后的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220912
[10]	廖周俊, 杨少华, 刘立鑫, 胡晟, 陈轶晖, 康强, 张小文. AK4对肝内胆管癌细胞HUCCT1增殖、迁移的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220611
[11]	赵斌, 段元鹏, 张国颖, 毕城伟, 杨李波, 施致裕, 杨勇, 张建朋, 高婷. CircRNA EZH2通过调控miR-30c-5p促进前列腺癌细胞增殖和迁移, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220731
[12]	马燕粉, 胡建, 张宁, 武倩, 王晓琴. 肺腺癌性与结核性胸腔积液患者凝血指标变化及异常模式, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211021
[13]	杨兰, 贾霄, 姜奕彤, 崔琪, 刘光赐, 何颖红. UBE2C基因沉默表达对人胃癌AGS细胞增殖和迁移的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210504
[14]	吴琪燕, 边革元, 程绘珺, 李娇霞, 王书廷, 黄照略. 肺腺癌预后因素及血清肿瘤标记物的诊断效能, 昆明医科大学学报.
[15]	庞月文, 巩会杰, 王玲, 时京, 段珺耀, 冯营营, 闫永吉. 老鹳草素对去势抵抗性前列腺癌细胞增殖与迁移能力的影响, 昆明医科大学学报.
[16]	孔祥东, 袁绍峰, 潘良明, 曾林文, 吴鸣, 沈建良. 红花黄色素对乳腺癌细胞增殖和迁移的抑制作用及其分子机制, 昆明医科大学学报.
[17]	朱中山, 严文辉, 李小兵, 杨洲, 白鹏. 200例肺腺癌脑转移患者驱动基因突变情况及预后关系, 昆明医科大学学报.
[18]	刘立鑫. 二甲双胍对肝癌细胞HCCLM3生物学行为的影响, 昆明医科大学学报.
[19]	史兆坤. 单核细胞趋化蛋白-1趋化巨噬细胞迁移与侵袭的体外实验研究, 昆明医科大学学报.
[20]	刘佳鑫. SDF-1/CXCR4在恶性胶质瘤细胞体外增殖、迁移及侵袭中的作用, 昆明医科大学学报.